Facing steep competition, Novo Nordisk has slashed the price for its weight loss drug Wegovy — temporarily, at least.

In sensitivity analyses, we examined the potential influence of a drug’s cost and budget impact on the restrictiveness of coverage. Because the prices that health plans negotiate with drug ...